LIVE

/Cosmic Eclipse/Reshiram & Zekrom-GX

Variants

AVOID · Conviction 2/10

Reshiram & Zekrom-GX

Cosmic Eclipse · #157 · Rare Holo GX

Live NM ask

€11.57

PSA 9

€0.00

USD source

PSA 10

€0.00

USD source

Composite

2.2

Confidence 2/10

2.2

Not yet verified

View listing →

Buy range€55.23 – €72.22Suspect — verify variant

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

No price history available for this card yet.

Investment thesis

Sub-score breakdown · ROI projections

2.2

SCORE / 10

Liquidity

0.0

Scarcity

8.0

Era potential

2.8

Friction

1.5

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 31.42%Total population

PSA 10

2,022

PSA 9

2,668

PSA 8

1,179

Total graded

6,435

Gem rate 31.42%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

Cosmic Eclipse's Reshiram & Zekrom-GX (#157) currently trades at €11.57 in the raw market. By market value it ranks #55 of 272 in Cosmic Eclipse — the 80th percentile of the set. Market data is informational only and does not constitute investment advice.